Four Preview Videos in the Footer
A change of plans as earlier they were going to continue amidst the market. It is the 64th to be pulled this year. BD
The South San Francisco, Calif.-based provider of systems designed to improve the productivity of laboratories had previously planned to issue 5.3 million shares for a total raise of $79.5 million, according to a regulatory filing. The price range was supposed to be $14 to $16 a share.
Fluidigm pulls IPO because of weak market conditions » VentureBeat
Pharmacy Benefit Managers Are Not Much More Than “Complex Well-Greased Algorithmic Human Scoring Machines” That Deny or Allow Access To Drugs To Create/Substantiate Big Corporate ProfitsSo let’s get down to what’s really happening here. Once upon a time the PBM models were a diff[...]
Optum/United Healthcare Quietly Sold Optum Hospice to Compassus in December of 2016-And Compassus Is Now Contracted Under Optum Services to Manage the Facilities, Services and Provide the OptumCare DoctorsOptum certainly kept this very quiet when they sold their hospice facilities to Compassus and I don’[...]
Algorithms, Scoring Metrics, Privacy and more in today’s Healthcare business world–The Healthcare Algo CartelThis is a video of a recent presentation I did at the 74th Annual AAPS (American Association of Phys[...]
Pharmacy Benefit Managers Invade Medical Records and Electronically Connect Cash Patients to RX Discount Cards-OptimizeRX-to SingleCare to OptumRXThis should not really come as a big surprise as what hasn’t the pharmacy benefit managment business[...]
“One Trick Algo World” Needs to be Licensed and Indexed–Spurious Correlations “For Profit” Are Out of ControlWith prediction tools and apps being all the rage today, their reliability and accuracy are not alwa[...]
0 comments :
Post a Comment
Click to see the code!
To insert emoticon you must added at least one space before the code.